KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762 | +173.1% | 568,298 | +591.7% | 0.06% | +85.7% |
| Q4 2022 | $279 | -100.0% | 82,162 | -57.2% | 0.04% | -77.4% |
| Q4 2021 | $1,234,000 | +19.8% | 191,976 | +8.5% | 0.16% | +47.6% |
| Q3 2021 | $1,030,000 | +242.2% | 176,996 | +507.4% | 0.10% | +208.8% |
| Q2 2021 | $301,000 | -6.5% | 29,138 | -4.8% | 0.03% | -35.8% |
| Q1 2021 | $322,000 | -5.0% | 30,592 | +39.7% | 0.05% | -3.6% |
| Q4 2020 | $339,000 | – | 21,903 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |